Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-048595
Filing Date
2023-09-07
Accepted
2023-09-07 16:00:09
Documents
1
Period of Report
2023-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4135
  Complete submission text file 0001209191-23-048595.txt   5664
Mailing Address 171 MAIN STREET #225 LOS ALTOS CA 94022
Business Address
Scott Randal W. (Reporting) CIK: 0001337801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 231242199

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations